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HIV inactivationOral transmission of human immunodeﬁciency virus (HIV) in adult populations is rare. However, HIV spread
across fetal/neonatal oropharyngeal epithelia could be important in mother-to-child transmission. Analysis of
HIV transmission across polarized adult and fetal oral epithelial cells revealed that HIV transmigrates through
both adult and fetal cells. However, only virions that passed through the fetal cells – and not those that passed
through the adult cells – remained infectious. Analysis of expression of anti-HIV innate proteins beta-
defensins 2 and 3, and secretory leukocyte protease inhibitor in adult, fetal, and infant oral epithelia showed
that their expression is predominantly in the adult oral epithelium. Retention of HIV infectivity after
transmigration correlated inversely with the expression of these innate proteins. Inactivation of innate
proteins in adult oral keratinocytes restored HIV infectivity. These data suggest that high-level innate protein
expression may contribute to the resistance of the adult oral epithelium to HIV transmission.an Francisco, Department of
ov).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The interaction of HIV with the mucosal epithelia of the oro-
pharyngeal, gastrointestinal, and genital (anorectal and cervicovagi-
nal) tracts – which involves the translocation of the virus from the
mucosal surface to HIV-susceptible intraepithelial and subepithelial
immune cells – is the ﬁrst step in the establishment of systemic HIV
infection (Anderson et al., 2010; Pope and Haase, 2003). However, the
ability of HIV to initiate systemic infection through exposure to these
various epithelia varies considerably. While transmission through the
adult oral cavity is rare (Page-Shafer et al., 2006; Tudor-Williams and
Lyall, 1999), mother-to-child transmission (MTCT) through the
neonatal oral and/or gastrointestinal epithelia is common (De Cock
et al., 2000; Luzuriaga, 2007; Mandelbrot et al., 1999). Transmission is
alsomore frequent through the adult anogenital tract (Anderson et al.,
2010; Pope and Haase, 2003) than it is through the adult oral route
(Scully and Porter, 2000). Thus, different mucosal epithelia transmit
HIV infection to different degrees, but the mechanisms underlying
these differences are poorly understood.
Orally transmitted HIV in the fetus/neonate may come from
amniotic ﬂuid in utero (Jaspan et al., 2004; Maiques et al., 2003;
Mundy et al., 1987) and from amniotic and cervicovaginal ﬂuids at
birth and in breast milk postnatally (Nussenblatt et al., 2005; Semba,2000; Semba and Neville, 1999; Willumsen et al., 2000). While
antiretroviral therapy (ART) has been shown to reduce the rates of
MTCT of HIV, the rate of MTCT without ART has been estimated to be
about 15% in Europe and 25–30% in African and Asian countries (De
Cock et al., 2000; Luzuriaga, 2007). By contrast, the rate of oral HIV
transmission in adults has been estimated to be only about 0.004% per
exposure (del Romero et al., 2002; Page-Shafer et al., 2002; Royce et
al., 1997; Vittinghoff et al., 1999), suggesting that the mechanisms of
HIV transmission via fetal/neonatal and adult oropharyngeal epithelia
are different.
Application of HIV to human vaginal, cervical, and intestinal tissue
explants ex vivo leads to the migration of HIV across these epithelia
(Hladik et al., 2007; Maher et al., 2005; Shen et al., 2010; Shen et al.,
2009; Shen et al., 2010). These results indicate that the virus can
transmigrate across intact mucosal epithelia, allowing it to infect
intraepithelial and submucosal HIV-susceptible immune cells and
therefore initiate systemic infection. In vitro studies using single-
layer, polarized epithelial cells show that virus transmigration is
mediated by transepithelial transcytosis without infection of the
epithelial cells. HIV transepithelial transcytosis has been well
documented in polarized cells of vaginal, endometrial, and intestinal
origin (Bobardt et al., 2007; Bomsel, 1997; Hocini et al., 2001; Hocini
and Bomsel, 1999; Meng et al., 2002; Saidi et al., 2007). However, HIV
transcytosis via adult and infant/fetal oral epithelial cells has not been
well investigated, even though differences between adult and infant/
fetal oral epithelia may help to account for the higher rate of oral
transmission in infants.
212 S.M. Tugizov et al. / Virology 409 (2011) 211–222To better understand the mechanisms underlying resistance and
susceptibility to HIV transmission across fully developed and
developing oral epithelia, respectively, we established monostratiﬁed
polarized oral epithelial cells from fully developed, mature, adult
epithelium and the developing, less mature, fetal oral epithelium.
Using these polarized epithelial cell models, we show that the HIV
virions can traverse both adult and fetal oral epithelial cells by
transcytosis. However, during passage through the adult cells – but
not through the fetal cells – infectivity of the virions is greatly
diminished. High-level expression of the anti-HIV innate proteins
beta-defensins (HBD) 2 and 3 and secretory leukocyte protease
inhibitor (SLPI) in adult oral epithelial cells are associated with
reduction or loss of HIV infectivity.Results
HIV transcytosis across polarized oral epithelial cells
To study HIV transepithelial transmission across well-developed
adult oral and developing fetal oral epithelia, we established
monostratiﬁed polarized epithelial cells originating from adult tongue
and tonsil, as well as fetal tongue and oropharyngeal mucosal
epithelia. To compare HIV transcytosis of oral epithelial cells to that
of genital epithelial cells, we also used polarized adult endometrial
and cervical epithelial cells. Cells were grown on microporous ﬁlter
inserts, and their polarity was conﬁrmed by immunodetection of tight
junction proteins and measurement of paracellular permeability and
transepithelial resistance (TER). The tight junction proteins occludin
(Fig. 1A) and ZO-1 (data not shown) were both found to be localized
to the lateral membranes of polarized cells, consistent with the
presence of tight junctions. To conﬁrm the functional status of the
tight junctions, paracellular permeability and TER were measured in
polarized cells that were either untreated or treated with EDTA to
dissociate the tight junctions. A substantial increase in [3H] inulin
passage from the apical surface to the basolateral compartment and a
decrease in TER in EDTA-treated cells in comparison to control, EDTA-
untreated cells were observed. These ﬁndings indicate the formation
of a tight, polarized, epithelial monolayer (Fig. 1B).
HIV transcytosis was examined using cell-free and cell-associated
dual (R5/X4)-tropic HIV-1SF33 virus, which was added to the apical
membranes of polarized cells. For cell-associated virus, we used HIV-
infected peripheral blood mononuclear cells (PBMCs). Previous
reports have shown that 3-h incubation of either cell-free or cell-
associated virus with polarized epithelial cells is sufﬁcient for HIV
transcytosis across these cells (Bomsel, 1997; Carreno et al., 2002;
Hocini et al., 2001). Therefore, this time period was used for our
transcytosis experiments. HIV transcytosis was evaluated by detection
of HIV-1 p24 in the lower chamber of the ﬁlter inserts using an ELISA
p24 detection assay. We compared transcytosis of cell-free and cell-
associated HIV-1SF33 virions in polarized endometrial (HEC-1A), adult
tongue (HSC-3sort, ATNG#1), fetal tongue (FTNG#1), and adult
cervical (CERV#1) epithelial cells (Fig. 1C). Transcytosis of cell-free
HIV-1SF33 virus in all polarized cells was at a low level, i.e., about
0.005% of viruses (from the original inoculum) transmigrated the
polarized monolayer. In contrast, transcytosis of cell-associated HIV-
1SF33 virus was about 10-fold higher. No PBMCs were detected in the
lower chambers, indicating that PBMCs did not migrate into lower
chambers through polarized cells.
To determine whether the interaction of cell-free virus or HIV-
infected PBMCs from the apical surface of epithelial cells altered the
integrity of polarized epithelial cells, we examined the TER and
paracellular permeability of the adult and fetal polarized monolayers
during transcytosis. As a control, cell junctions were disrupted by
incubation of polarized cells with 10 mM EDTA. We found that TER
and paracellular permeability of polarized epithelial cells were notchanged by transcytosis of either cell-free or cell-associated HIV-1SF33
virions (Fig. 1D).
Expression of HIV coreceptors in adult and fetal oral epithelial cells
HIV coreceptors CXCR4, CCR5, galactosyl ceramide (GalCer), and
heparan sulfate proteoglycans (HSPG) may play a critical role in HIV
transcytosis (Alfsen and Bomsel, 2002; Alfsen et al., 2005; Bobardt
et al., 2007; Bomsel, 1997; Yahi et al., 1994). It has been well
documented that polarized endometrial and vaginal epithelial cells do
not express CD4 but may express one or more of these HIV
coreceptors (Bobardt et al., 2007; Bomsel, 1997; Hocini et al., 2001;
Hocini and Bomsel, 1999; Saidi et al., 2007). We used FACS and
immunoﬂuorescence assays to determine whether CD4, CXCR4, CCR5,
GalCer, and HSPG are expressed in polarized oral epithelial cells.
Analysis of CD4 expression in adult and fetal oral epithelial and
cervical and endometrial cells showed that CD4 was not detectable in
any of these cell lines (data not shown). Detection of the HIV
coreceptors GalCer, HSPG, CXCR4, and CCR5 in polarized oral
epithelial cells by FACS revealed that primary adult and fetal oral
epithelial cells, as well as cervical epithelial cells, expressed all of
these receptors (Fig. 2A). Expression of CXCR4 and CCR5 in
immortalized adult HSC-3sort tongue cells was not detectable, and
only low-level expression of these receptors was found in immortal-
ized HEC-1A endometrial cells. Confocal microscopy showed that
these receptors were present on the apical surfaces (Fig. 2B).
To determine whether the expression of HIV coreceptors in
established, polarized cells in vitro correlates with their expression
in oral mucosal epithelia in vivo, we immunostained adult and fetal
biopsy tissue sections for the HIV receptors CD4, CXCR4, CCR5, GalCer,
and HSPG. Expression of CD4 was not detected in either adult or fetal
oral epithelia. CXCR4 and CCR5were detectedmostly within basal and
parabasal cells (Fig. 2C, white arrowheads) in 6 of 7 (85.7%) buccal
tissue samples; the more superﬁcial layers of the adult buccal
epithelia were negative. GalCer and HSPG were both detected within
all layers of the adult buccal epithelia (Fig. 2C). In fetal oral and
intestinal tissues, CXCR4 and CCR5 were detected in 5 of 10 (50%)
buccal, 7 of 9 (78%) oropharyngeal, and 4 of 8 (50%) intestinal tissue
samples (Fig. 2D). All were positive for GalCer and HSPG, primarily in
the more superﬁcial cell layers.
HIV transmission across adult oral epithelial cells leads to viral
inactivation, whereas HIV transcytosed across fetal epithelial cells
retains infectious activity
In the above experiments, we showed that the amount of HIV that
transmigrated across fetal and adult oral epithelia was about similar
(Fig. 1C). We next sought to determine if the levels of infectious virus
were similar. To determine the infectivity of transmigrated cell-free
virions, we performed transcytosis assays with cell-free HIV-1SF33 in
polarized adult tongue and tonsil, fetal tongue and oropharyngeal,
and adult endometrial and cervical epithelial cells. The infectious
activities of transmigrated virions were examined in target PBMCs
using a reverse transcriptase (RT) assay after 7 days. In this analysis,
no RT activity was detected in target PBMCs infected with cell-free
virions transcytosed through any of these cells (data not shown).
Similar data were obtained from 4 independent experiments. This
observation may have reﬂected the low levels of cell-free HIV
transcytosis via polarized epithelial cells (Fig. 1C).
To examine the infectious activity of transmigrated, cell-
associated virions, HIV-1SF33 -infected PBMCs were added to the
apical surfaces of polarized adult and fetal tongue epithelial cells
and adult endometrial cells. After 3 h, one-third of the culture
medium from the lower chamber was collected for detection of HIV-
1 p24 by ELISA. The remaining media, along with the target PBMCs,
were cultured for the next 7 days, and the PBMCs were used for RT
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rates of HIV transcytosis through adult and fetal tongue epithelial
cells and adult endometrial cells were comparable. These ﬁndings
indicate that about the same numbers of virions transmigrated
through each cell type. However, virions that transmigrated across
adult tongue epithelial cells showed no RT activity in target PBMCs
(Fig. 3A). In contrast, virions that passed through fetal tongue
epithelial cells and adult endometrial cells did show RT activity inFig. 1. Establishment of polarized adult and fetal oral epithelial cells and transcytosis of HIV
were grown under polarizing conditions on Transwell ﬁlter inserts for 7–14 days. Expression
were stained in blue. Cells were analyzed by confocal microscopy, and images were obtained
plane. (B) Transepithelial resistance (TER) and paracellular permeability of polarized adu
monolayers and passage of radioactive 3H-inulin through paracellular spaces. As a positiv
measurement. Error bars show±standard error of themean (SEM) (n=3). (C) Transcytosis
1SF33 (106 PBMCs) were added to the apical membranes of polarized endometrial (HEC-1A),
epithelial cells. After 3 h, culture media from the lower chambers were examined for HIV-1 p
transcytosis. For transcytosis assays, cell-free and cell-associated HIV-1SF33 were added to th
cells for 3 h. One set of ﬁlter inserts was without virus, and the next set of inserts was witho
permeability of polarized cells were examined by Millicell-ERS voltohmmeter and radioacttarget PBMCs. These data indicate that the cell-associated virions
that had transmigrated across adult oral epithelial cells were not
infectious in the target PBMCs, but that those that had passed
through fetal oral epithelial and adult endometrial cells retained
infectious activity.
Analysis of the RT activity of PBMCs infected with transmigrated,
cell-associated HIV-1SF33 virions in multiple experiments using
several different adult and fetal oral epithelial cell lines (Fig. 3B). (A) Formation of tight junctions in polarized adult and fetal oropharyngeal cells. Cells
of occludin, a marker for tight junctions, was examined by immunostaining. Cell nuclei
approximately 3 μm below the apical surface of polarized cells in the x–y (horizontal)
lt and fetal oral epithelial cells were examined by measuring electrical resistance of
e control, cell junctions were disrupted by incubating cells with 10 mM EDTA before
of cell-free and cell-associated HIV. Cell-free (20 ng p24/insert) and cell-associated HIV-
adult tongue (HSC-3sort, ATNG#1), fetal tongue (FTNG#1), and adult cervical (CERV#1)
24 using an ELISA. (D) Analysis of the integrity of polarized oral epithelial cells after HIV
e apical membranes of polarized adult (ATNG#1) and fetal tongue (FTNG#1) epithelial
ut virus and treated with EDTA for 30 min prior to measurement. TER and paracellular
ive 3H-inulin passage, respectively.
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epithelial cells had a strong tendency to lose their infectious activity
for target PBMCs. In contrast, the infectious activity of virions that hadtraversed fetal oral epithelial cells was well preserved. HIV-1SF33
virions that transmigrated through adult endothelial and cervical
epithelial cells were also infectious (Fig. 3B).
Fig. 3. Analysis of infectious activity of HIV transcytosed through adult and fetal oral epithelial cells. (A) Transcytosis of cell-associated HIV-1SF33 virus across adult (ATNG#1) and
fetal tongue (FTNG#1) epithelial cells and adult endometrial cells was examined. After 3 h, one-third of culture media with PBMCs from the lower chambers was collected and used
for an ELISA p24 assay. The rest of the media were maintained with target PBMCs for the next 7 days, and the infectious activity of the virus was determined using an RT assay. Data
shown are mean±SEM from 3 ﬁlter inserts. Similar results were obtained in 3 independent experiments. (B) Transcytosis of cell-associated HIV-1SF33 through adult endometrial
HEC-1A, cervical (CERV#1), tongue (HSC-3sort, ATNG#1, ATNG#2), and tonsil (ATSL#1, ATSL#2) epithelial cells, as well as fetal tongue (FTNG#1, FTNG#2, FTNG#3) and
oropharyngeal (FORPH#1, FORPH#1) epithelial cells. Infectious activity of transcytosed virions was examined using an RT assay after 7 days of culturing PBMCs from the lower
chambers. Each data symbol (circle) indicates one experiment, and each experiment used three separate ﬁlter inserts. n, Number of ﬁlter inserts. Horizontal lines represent median
values. (C) Cell-associated R5-tropic HIV-1SF170 and X4-tropic HIV-192UG029 were used for transcytosis through endometrial (HEC-1A), adult tongue (HSC-3sort, ATNG#1), tonsil
(ATSL#1), and fetal oropharyngeal (FORPH#1, FORPH#2, FORPH#3) epithelial cells. After 1, 2, and 3 weeks of transcytosis, the infectious activity of virions in PBMCs was examined
using an RT assay. Results shown are from one representative experiment out of two experiments. Error bars show±SEM (n=3).
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adult oral epithelial cells but not in fetal oral epithelial cells
To determine the infectious activity of clinical HIV-1 isolates after
their transmigration across adult and fetal oral epithelial cells, we
performed transcytosis assays with cell-associated X4-tropic HIV-
192UG029 and R5-tropic HIV-1SF170 primary isolates in adult endometrial,
tongue and tonsil, and fetal tongue and oropharyngeal polarized
epithelial cells (Fig. 3C). The infectious activity of transmigrated virionsFig. 2. Expression of HIV-1 coreceptors in adult and fetal oral and fetal intestinal epithelia. (
CXCR4, CCR5, GalCer, and HSPG in adult (HSC-3sort and ATNG#1 tongue, and ATSL#1 tonsil) a
adult endometrial (HEC-1A) and cervical (CERV#1) epithelial cells, was examined by ﬂow c
HIV coreceptors on the apical surfaces of polarized oral epithelial cells. Polarized adult and f
cells were immunostained for HIV coreceptors (green). Nuclei were counterstained in blue.
plane. Original magniﬁcation is ×600. (C and D) Expression and localization of HIV-1 core
epithelia. Tissue sections were immunostained with antibodies to GalCer, HSPG, CCR5, or CX
panels are shown. GR, granulosum; SP, spinosum; BL, basal; LP, lamina propria; EP, epith
epithelium. Original magniﬁcation is ×600 (A, upper and middle panes; B, all panels). Origwasexaminedafter 1, 2, and3 weeks in target PBMCs. Thesedata showed
that virions that traversed adult oral epithelial cells were not infectious,
but those transmitted through adult endometrial and fetal oral epithelial
cells were infectious in PBMCs and that their RT values increased with
time. Transmigration of infectious virions was also detected through
polarized primary cervical epithelial cells (data not shown). Thus,
transmission of HIV-1 clinical isolates through adult oral epithelial cells
caused their complete inactivation,whereas viral transmigration through
fetal and cervical epithelial cells did not affect their infectious activity.A and B) Expression of HIV-1 coreceptors in polarized epithelial cells. (A) Expression of
nd fetal (FTNG#1 tongue and FORPH#1 oropharyngeal) oral epithelial cells, as well as in
ytometry. The mean ﬂuorescence intensity is shown. *Not detected. (B) Localization of
etal oral epithelial cells were ﬁxed with 4% paraformaldehyde, and non-permeabilized
Cells were analyzed by confocal microscopy, and images are shown in the x–z (vertical)
ceptors in adult (C), fetal oral (D, upper panels), and fetal intestinal (D, lower panels)
CR4 (all green) or their isotype controls. Cell nuclei were stained in blue. Only merged
elium. White lines indicate the border between the lamina propria and the mucosal
inal magniﬁcation is ×400 (A, lower panels).
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cells
To understand the mechanisms of HIV inactivation in adult oral
epithelial cells and the preservation of infectious activity in fetal oral
epithelial cells, we examined the expression of anti-HIV innate proteins
beta-defensins (HBD) 1, 2, and 3 and secretory leukocyte protease
inhibitor (SLPI) (Dale et al., 2001; Dunsche et al., 2002; Jana et al., 2005;
Moutsopoulos et al., 2007;Quinones-Mateu et al., 2003; Sun et al., 2005)
in both cell types. In an immunoﬂuorescence assay, we found that about
70% of adult and fetal oral epithelial cells and about 80% of cervical
epithelial cells were positive for HBD1 (data not shown).We also foundFig. 4. Expression of anti-HIV innate proteins in adult, fetal, and infant oral epithelial cells. (A) E
cells were grown under polarizing conditions and immunostained for HBD2, HBD3, and SLPI.
show±SEM (n=3). (B) Secretion of HBD2, HBD3, and SLPI from polarized and non-polarize
media were collected separately from apical and basolateral membranes of polarized cells. In
HBD2, HBD3, and SLPI wasmeasured using an ELISA detection kit for each protein. Error bars sh
oropharyngeal (22weeks old), and infant tonsil epithelia (3months old). Tissue sectionswere i
Cell nuclei are counterstained in blue. Cells were analyzed by confocal microscopy. Original mthat 60–80% of adult oral epithelial cells were positive for HBD2, HBD3,
and SLPI (Fig. 4A). However, the fetal oral epithelial cells had an
approximately 5- to 10-fold lower level of expressionof thesemolecules
thandid the adult cells. Furthermore, theexpressionofHBD2,HBD3, and
SLPI in adult cervical epithelial cells was 2- to 5-fold lower than that in
adult oral epithelial cells. None of these proteins were detected in HEC-
1A endometrial cells (data not shown).
Secretion of HBD2, HBD3, and SLPI was measured for the polarized
and non-polarized adult and fetal oral and adult cervical cells using an
ELISA assay. These data revealed that all three proteins were secreted
at the highest levels only from polarized adult tongue and tonsil
epithelial cells (Fig. 4B). Their secretion from non-polarized adultxpression of anti-HIV innate proteins in polarized epithelial cells. Adult and fetal epithelial
Cells were analyzed by confocal microscopy, and positive cells were counted. Error bars
d adult tongue and tonsil, fetal oropharyngeal, and adult cervical epithelial cells. Culture
parallel experiments, culture media were collected from non-polarized cells. Secretion of
ow±SEM (n=3). (C) Expression of anti-HIV proteins in adult buccal (40 years old), fetal
mmunostainedwith antibodies toHBD2, HBD3, or SLPI (all green) or their isotype controls.
agniﬁcation is ×600. GR, granulosum; SP, spinosum; LP, lamina propria; EP, epithelium.
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from polarized adult oral epithelial cells. Secretion of HBD2 and HBD3
from fetal oropharyngeal and adult cervical epithelial cells was about
10- to 15-fold lower than that of adult oral epithelial cells. High-level
SLPI secretion was detected only in adult tongue and tonsil epithelial
cells, and SLPI secretion from fetal oropharyngeal and adult cervical
epithelial cells was not detectable.
We next examined the expression of anti-HIV proteins in adult and
fetal oral biopsy tissues. Immunoﬂuorescence analysis of 5 adult buccal
and 6 fetal oropharyngeal (Fig. 4C) and 8 buccal (data not shown) tissue
explants for HBD2, HBD3, and SLPI showed that HBD2, HBD3, and SLPI
were all strongly expressed in the adult oral epithelium (Fig. 4C). All
three proteins were detected both within cells and in the extracellular
environment, consistent with their being secreted. In contrast,
expression of these proteins in fetal buccal and oropharyngeal epithelia
was mainly negative, and only weak positive signals were observed in
only small areas of fetal epithelia (Fig. 4C). We also examined HBD2,
HBD3, and SLPI expression in 3 infant tonsil epithelia and found that
they were all negative or only weakly positive for these proteins.
Functional role of anti-HIV innate proteins in inactivation of HIV during
transepithelial transmigration
To determine the functional role of innate proteins in the inacti-
vation of HIV during transcytosis in adult oral epithelial cells, weFig. 5. The role of anti-HIV innate proteins in infectious activity of transcytosed HIV-1 throu
transfected with siRNA against HBD1, HBD2, HBD3, and SLPI. Control cells were transf
immunostained for HBD1, HBD2, HBD3, and SLPI. Expression of innate proteins in cells tre
microscopy, and positive cells were counted in 10 randomly chosen ﬁelds. Error bars sho
Transwell inserts and transfected with anti-HBD3 and SLPI siRNAs and control siRNA. After 3
(C) Polarized adult tonsil cells transfected with speciﬁc siRNA or control siRNA, and untreated
removed, and target PBMCs in the lower chambers were cultured for the next 10 days, an
transcytosis. Control, cells transfected with irrelevant siRNA. Untreated cells, cells were not
from one representative experiment out of two experiments. (D) Antibodies to HDB2, HBD3
delivery reagents. As a control, cells were treated with matched isotype antibodies. After 16
of traversed virions was determined in PBMCs from the lower chamber. Input virus, the RT
antibodies. Error bars show±SEM (n=3). Similar results were obtained in 4 independentinterfered with innate protein function using two independent
approaches: inhibition of innate protein expression and intracellular
neutralization. For inhibition of innate protein expression, polarized
adult tonsil epithelial cells were treated with siRNA against HBD1,
HBD2, HBD3, or SLPI. As a control, we used an unrelated siRNA.
Immunostaining of HBD1, HBD2, HBD3, and SLPI after 3 days showed
that treatment of cells with speciﬁc siRNAs reduced expression of
innate proteins by about 60–70% (Fig. 5A). A Western blot assay also
showed that siRNA treatment reduced HBD3 and SLPI expression
below detectable levels (Fig. 5B). These cells were then used for HIV-
1SF33 cell-associated transcytosis assays. The TER of these epithelia
was similar to the TER of untreated polarized cells (about 650 Ω/cm2
in both treated and untreated cells), indicating that the siRNA
treatment did not disrupt tight junctions. Measurement of the RT
activity of target PBMCs after 10 days showed that virions that had
traversed polarized cells treated with siRNA against HBD2, HBD3, and
SLPI were infectious (Fig. 5C). In contrast, virions that had traversed
cells treated with either anti-HBD1 siRNA or control siRNA did not
cause infection in target PBMCs, that is, no RT activity was detected in
PBMCs after 10 days.
In the next set of experiments, we neutralized intracellular innate
proteins in adult tongue epithelial cells using speciﬁc antibodies.
Antibody-mediated intracellular neutralization of viruses and pro-
teins has been shown (Bomsel et al., 1998; Burns et al., 1996; Devito
et al., 2000; Edelson and Unanue, 2001; Krautz-Peterson et al., 2008;gh adult oral epithelial cells. (A) Polarized adult tonsil (ATNSL#1) epithelial cells were
ected with irrelevant siRNAs or were untreated. After 3 days, cells were ﬁxed and
ated with siRNA and control siRNA, and in untreated cells, was analyzed by confocal
w±SEM. (B) Polarized adult tonsil (ATNSL#1) epithelial cells were grown in 6-well
days, cells were extracted, and HBD3 and SLPI were detected using aWestern blot assay.
cells were used for transcytosis of cell-associated HIV-1SF33. After 3 h, ﬁlter inserts were
d RT activity was determined. Input virus, the RT value of HIV-infected PBMCs before
treated with speciﬁc or control siRNA. Error bars show±SEM (n=3). Data shown are
, and SLPI were internalized into adult tongue epithelial cells (ATNG#1) using antibody
h, cell-associated HIV-1SF33 transcytosis was performed, and after 7 days, the RT activity
value of HIV-infected PBMCs before transcytosis. Control, transcytosis in the absence of
experiments.
218 S.M. Tugizov et al. / Virology 409 (2011) 211–222Wright et al., 2006). Antibodies against HBD2, HBD3, or SLPI and
isotype control antibodies were added to polarized adult tongue
epithelial cells with the lipid-based antibody-delivery reagent Ab-
DeliverIN™ (OZ Biosciences) to promote their internalization. The
TER in these epithelia was similar to the TER of untreated polarized
cells (about 600Ω/cm2 in both treated and untreated cells), indicating
that the antibody-delivery reagent did not disrupt tight junctions.
Measurement of SLPI secretion from cells treated with anti-SLPI
antibodies showed that internalization of antibodies completely
blocked the secretion of SLPI, indicating that antibodies in the
cytoplasm may inhibit secretion of innate proteins. Antibody-
internalized cells were then used for HIV-1SF33 cell-associated
transcytosis. Measurement of the RT activity of target PBMCs after
7 days showed that virions that had traversed polarized cells treated
with antibodies against HBD2, HBD3, and SLPI were infectious
(Fig. 5D). The RT values of these target PBMCs further increased
about 3- to 5-fold by the 14-day time point (data not shown). In
contrast, virions that had traversed cells treated with isotype control
antibodies did not cause infection in target PBMCs, that is, no RT
activity was detected in PBMCs after 7 and 14 days. Thus, reduction of
innate protein expression by siRNA and their intracellular neutrali-
zation by speciﬁc antibodies in adult tonsil and tongue epithelial cells
allowed transcytosed virions to remain infectious. These ﬁndings
strongly suggest that the innate proteins HBD2, HBD3, and SLPI are
responsible for the loss of virion infectivity during transcytosis.
Colocalization of HIV with HBD2 and -3 in the vesicular compartment
HBD2 and HBD3 inactivate HIV by direct interaction with the
virions (Cole et al., 2002; Wang et al., 2003, 2004; Weinberg et al.,
2006), which may occur during viral transcytosis. To determine
whether HBD2 and HBD3 colocalize with HIV in the vesicular
compartment during HIV transcytosis, we performed HIV transcytosis
assays in polarized adult tonsil epithelial cells. R5-tropic HIV-1 81-A
virus labeled with GFP (HIV-GFP) was added to the apical surfaces of
polarized cells, and after 2 h, cells were ﬁxed and immunostained for
early endosomal vesicles using antibodies against early endosomal
antigen 1 (EEA1) (Fig. 6, red). The same cells were also co-stained for
HBD2 or HBD3. Confocal microscopy revealed that the HIV-GFP signal
(Fig. 6, green) colocalized with EEA1, indicating the presence of
virions in the early endosomal compartment. Notably, HBD2 and
HBD3 (Fig. 6, blue) also colocalized with EEA1, indicating that HBD2
and HBD3 were present in the vesicular compartment. Furthermore,
HBD2 and HBD3 were also found to colocalize with both the GFP-
virions and EEA1 (Fig. 6, merged panel, white), suggesting that HBD2Fig. 6. Localization of HIV in the HBD2 and HBD3 containing early endosomal vesicles. GF
epithelial cells. Cells were incubated at 37 °C for 2 h. Cells were then ﬁxed and co-immunost
microscopy, and images were taken about 3 μm below the apical surface. The pink in merge
the merged panels indicates colocalization of HIV (green), HBD2 (blue), and EEA-1 (red), indand HBD3 may interact with virions in the vesicular compartment,
leading to inactivation of intracellular virus.
Discussion
Oral transmission is a potentially important, poorly understood
route of HIV infection.
Using a monostratiﬁed polarized oral epithelial cell model, we
showed that HIV can traverse both adult and fetal oral epithelial
cells; however, virions transmigrating through adult epithelial cells
were rendered noninfectious, whereas those that passed through
fetal epithelial cells remained infectious. We further found that HIV
inactivation by adult oral epithelial cells was associated with high-
level expression of the anti-HIV innate proteins HBD2, HBD3, and
SLPI.
Cell-free HIV-1 transcytosis in endometrial HEC-1 cells is substan-
tially lower than that of cell-associated transcytosis (Bomsel, 1997;
Hocini and Bomsel, 1999). Our data also showed higher levels of
transcytosis for cell-associated than for cell-free HIV across adult and
fetal oral epithelial cells (Fig. 1C). These data are consistent with a
recent report that exposure of the vaginal and cervical mucosa of
macaques to cell-associated simian immunodeﬁciency virus (SIV)
leads to rapid transmucosal transmission of SIV (Salle et al., 2010).
Efﬁcient transcytosis of cell-associated HIV appears to be mediated by
the formation of viral synapses between HIV-infected lymphocytes
and the apical surfaces of epithelial cells (Alfsen et al., 2005; Ganor
et al., 2010). Interaction of HIV envelope proteins with the heparan
sulfate proteoglycan (HSPG) agrin and GalCer and subsequent
cooperation of HSPG and GalCer with beta-1 integrin were critical
for the synapse formation between HIV-infected lymphocytes and
epithelial cells (Alfsen et al., 2005). Such viral synapses facilitated
rapid viral spread via synaptic contact and transcytosis of virions
through epithelial cells (Alfsen et al., 2005).
Expression of coreceptors that may play a role in HIV transcy-
tosis, i.e., GalCer, HSPG, CXCR4, and CCR5, in polarized adult and
fetal oral epithelial cells and tissues (Fig. 2) was consistent with
previously reported detection of these receptors in various epithe-
lial tissues, including oral, intestinal, vaginal, and uterine (Bobardt
et al., 2007; Dwinell et al., 1999; Kumar et al., 2006; Yeaman et al.,
2004, 2003). Importantly, we found that, while HIV can transmi-
grate across intact adult and fetal oral epithelial cells, transmission
of infectious virus is inhibited through adult epithelial cells (Fig. 3).
Higher level expression and secretion of the anti-HIV innate
proteins HBD2, HBD3, and SLPI were found in adult oral epithelial
cells relative to fetal and infant oral epithelial cells (Fig. 4). ThisP-labeled HIV-1 81-A virus was added to the apical surfaces of polarized adult tonsil
ained for EEA1 (red) and HBD2 or HBD3 (both in blue). Cells were analyzed by confocal
d panels indicates colocalization of EEA1 (red) with HBD2 or HBD3 (blue). The white in
icating colocalization of HBD2 and virions in the EEA1-positive early endosomes (red).
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transmitted across adult oral epithelial cells. High-level expression
of innate proteins, including beta-defensins and SLPI, in the normal
adult oral epithelium has been reported previously (Dale et al.,
2001; Dunsche et al., 2002; Jana et al., 2005; Moutsopoulos et al.,
2007; Quinones-Mateu et al., 2003; Sun et al., 2005). However,
expression of HBD2, HBD3, and SLPI in the fetal and infant oral
mucosal epithelia was barely detectable (Fig. 4). This ﬁnding
suggests that fetuses and infants may have developing mucosal
innate immune systems, and therefore, transmission of infectious
HIV via fetal and neonatal/infant mucosal epithelia could occur
more readily. Developmental studies have shown that the level of
expression of innate proteins in mammals during their fetal/
neonatal period is weaker than during their adult period (Meyer-
holz et al., 2006; Patil et al., 2005). All these observations are
consistent with the ﬁnding that there is a higher level of oral
transmission of HIV/SIV in neonatal macaques than in (Ruprecht
et al., 1998) adult primates (Baba et al., 1996; Ruprecht et al., 1998).
We observed that transcytosis of HIV across polarized endometrial
and cervical epithelia did not affect viral infectivity (Fig. 3), and this
waswell correlatedwith the absence or low-level expression of HBD2,
HBD3, and SLPI in these cells (Fig. 4). Expression of HBD2, HBD3, and
SLPI in the genital mucosa was not stable and depends on the
menstrual cycle, i.e., HBD3 and SLPI express during the secretory
phase, and HBD2 expression has been detected only during
menstruation (King et al., 2003a,b; Moriyama et al., 1999).
Restoration of HIV infectious activity in adult oral epithelial cells
by siRNA-mediated silencing of HBD2, HBD3, and SLPI gene
expression and by antibody-mediated intracellular neutralization
of these proteins supports the idea that they play a critical role in
reduction of viral infectivity (Fig. 5). HBD2 and HBD3 were present
in the vesicular compartment of polarized oral epithelial cells and
colocalized with HIV virions (Fig. 6). This ﬁnding suggests the
possible intravesicular interaction of defensins with virions, which
can lead to the inactivation of virions during transcytosis. Further-
more, secretion of HBD2 and HBD3 from polarized cells may also
inactivate extracellular virus. Defensins may directly bind to the HIV
envelope (Cole et al., 2002; Wang et al., 2003, 2004; Weinberg et al.,
2006), and HBD2 and HBD3 are known to inactivate both X4 and R5
viruses (Sun et al., 2005). Furthermore, defensins bind to biological
membranes and form multimeric pores, leading to disruption of
membranes (Ganz et al., 1985; Hancock and Lehrer, 1998; Lehrer
and Ganz, 2002; Nizet et al., 2001; White et al., 1995; Zasloff, 2002).
Thus, it is possible that HIV inactivation in adult oral epithelial
cells could be due to HBD2- and HBD3-mediated disruption of viral
membranes.
SLPI reduces infectivity of both X4- and R5-tropic viruses;
however, it does not bind to virions directly but rather interacts
with HIV-susceptible cells (McNeely et al., 1995, 1997; Wahl et al.,
1997). Secretion of SLPI from the basolateral membranes of polarized
cells into the lower chambers of our ﬁlter inserts may have enabled
binding of SLPI to PBMCs leading to reduced entry of virus into target
cells. Therefore, in the adult oral epithelium, the combined effects of
HBD2 and HBD3 on intracellular and extracellular virus, and of SLPI on
target cells, may inactivate virions and reduce the susceptibly of target
PBMCs, respectively.
In summary, our data show that the resistance to HIV trans-
mission via the adult oral epithelium could be due to high levels of
innate protein expression that reduce infectivity of virus during its
migration within the oral mucosal epithelial compartment. Fetal
and infant epithelia, which lack expression of innate proteins, may
allow transepithelial transmigration of infectious virions and
therefore can be vulnerable to HIV transmission. Approaches
designed to increase the levels of innate defense proteins in such
epithelia may be of value in reducing the risk of HIV transmission by
the oral route.Materials and methods
Viruses
The laboratory-adapted dual (X4-R5)-tropic HIV-1SF33 (Levy and
Shimabukuro, 1985), R5-tropic HIV-1SF170, and X4-tropic HIV-
192UG029 primary clinical isolates were grown in peripheral blood
mononuclear cells (PBMCs) from HIV-negative individuals. PBMCs
were isolated from buffy coats by Ficoll-Hypaque gradient centrifu-
gation and were activated prior to infection with 2.5 μg/ml phytohe-
magglutinin (Sigma) and 1 μg/ml interleukin-2 (BD Bioscience) for
3 days. Green ﬂuorescent protein (GFP)-expressing virions were
produced by co-transfection of 293T cells with proviral DNA of X4-
tropic HIV-1NL4-3 and R5-tropic HIV-181A, and an expression vector
encoding a GFP-Vpr fusion protein, as described (Schaeffer et al.,
2001). After 48 h, the released virions were concentrated by
ultracentrifugation at 20,000 rpm in an SW41 rotor for 2 h at 4 °C.
The viral stocks were quantitated for p24 antigen using a p24 ELISA
assay and stored in aliquots at −80 °C.
Establishment of polarized adult and fetal oral epithelial cells
Polarized HSC-3sort tongue epithelial cells were established in our
laboratory (Tugizov et al., 2003), and polarized HEC-1A endometrial
epithelial cells were propagated as described (Bomsel, 1997). Two
primary adult ectocervical epithelial cell lines (CERV#1 and CERV#2)
were purchased from Lonza. To establish polarized cells from primary
oral epithelial cells, we propagated primary keratinocytes from two
adult tongue (ATNG#1, ATNG#2), three adult tonsil (ATNSL#1,
ATNSL#2, ATNSL#3), three fetal tongue (FTNG#1, FTNG#2,
FTNG#3), and three fetal oropharyngeal (FORPH#1, FORPH#2,
FORPH#3) tissue samples. Each primary keratinocyte culture origi-
nated from independent, HIV-negative adult donors and fetuses. One-
to two-millimeter pieces of adult and fetal epithelial tissues were
placed on Matrigel-coated plates in KGM-2 media (Clonetics) and
incubated at 37 °C in a humidiﬁed incubator containing 5% CO2.
Approximately 2–3 weeks later, keratinocyte outgrowths formed
around the tissue explants. They were trypsinized and expanded as
a primary culture in KGM-2 media and frozen at passage 3 or 4. The
purity of epithelial cells was examined by detection of pankeratin
using a cocktail of anti-keratin antibodies containing Ab-1 and Ab-2
(Thermo Scientiﬁc), and only those epithelial cell populations that
were 100% positive for keratin were used. Polarized cells were
established in 0.45-μm Transwell two-chamber ﬁlter inserts (12-well
inserts) as described in our previous work (Tugizov et al., 1998, 2003).
The polarity of epithelial cells was veriﬁed by immunodetection of the
tight junction proteins ZO-1 and occludin and measurement of
paracellular permeability and transepithelial resistance (TER), as
described previously (Tugizov et al., 1996, 1998, 2003). Brieﬂy, TER
was measured with an epithelial Millicell-ERS voltohmmeter. To
measure paracellular permeability, radioactive 3H-inulin (0.74 Ci/
mmol, Amersham) was added to the upper ﬁlter chamber. After
10 min, medium from the lower chamber was collected and
radioactivity was measured. To induce depolarization, cells were
treated with 10 mM EDTA for 30 min prior to measurements, and this
served as a positive control for the disruption of cell junctions.
Collection of tissues from adult, fetal, and infant oral mucosal epithelium
Approval for collection of oral biopsies was obtained from the
Institutional Review Board at the University of California, San
Francisco. Biopsies of buccal mucosa were obtained from healthy
HIV-seronegative adult volunteers (age range, 30–41 years) who had
no inﬂammation in the oral cavity (Department of Orofacial Sciences,
UCSF). Fetal buccal and oropharyngeal tissue explants were obtained
from fetuses 18 to 24 weeks old that had been aborted from HIV-
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ductive Sciences, San Francisco General Hospital). Infant tonsil tissues
from 3 infant cadavers (1 day old, 3 days old, and 3 months old) were
provided by Dr. Urcell (Department of Pathology, UCSF). These tissues
were used for immunostaining of innate proteins.
Confocal immunoﬂuorescence and ﬂow cytometry assays
Immunostaining of tissue sections and polarized epithelial cells
was performed as described (Tugizov et al., 2007, 2003). The
following antibodies were used for detection of receptors, tight
junctions, and innate immune proteins: mouse anti-CD4 (5 μg/ml)
(BD Bioscience); anti-CXCR4 (5 μg/ml) and anti-CCR5 (5 μg/ml) (both
from R&D and provided by the NIH AIDS Reagent program); rabbit
anti-GalCer (1:50) (Chemicon) and mouse anti-HSPG 10E4 (1:50)
(Seikagaku); rabbit anti-ZO-1 (1 μg/ml), -occludin (1 μg/ml), and
-claudin-1 (5 μg/ml) (all from Zymed); rabbit anti-human beta-
defensin 1 (HBD1) (1 μg/ml) (Abcam), goat anti-HBD2 (R&D) (10 μg/
ml), and mouse anti-HBD3 (Abcam) (10 μg/ml); and mouse anti-
secretory leukocyte protease inhibitor (5 μg/ml) (R&D). For detection
of HIV in the vesicular compartment, we used rabbit antibodies
against the early endosome marker EEA1 (5 μg/ml) (Abcam).
Secondary antibodies labeled with ﬂuorescein isothiocyanate (FITC),
tetramethyl rhodamine isothiocyanate (TRITC), or cyanine 5 (Cy5)
were purchased from Jackson Immunoresearch. The speciﬁcity of each
antibody was conﬁrmed by negative staining with the corresponding
primary isotype control antibody. Cell nuclei were counterstained
with TO-PRO-3 iodide (Molecular Probes) (blue). Immunostaining
and quantitative analysis were evaluated by two independent
investigators (RH and ST). Cells were analyzed using a krypton–
argon laser coupled with a Bio-Rad MRC2400 confocal head. The data
were analyzed using Laser Sharp software.
For ﬂow cytometry, polarized cells were dissociated enzyme-free
cell-dissociation buffer and incubated with antibodies to CCR5, CXCR4,
GalCer, and HSPG in PBS (pH 7.4) containing 1% bovine serum albumin
(BSA) for 1 h on ice. Cells were then washed, incubated with secondary
antibodies for 30 min at 4 °C, and analyzed in a FACScan cytometer
(Becton-Dickinson and Company, San Jose, California).
Assay for HIV transcytosis across polarized adult and fetal oral epithelial
cells
Transcytosis assays were performed as described previously
(Bomsel, 1997), with minor modiﬁcations. Prior to each experiment,
the polarization of cells was conﬁrmed by measuring TER. For
transcytosis assays with cell-free virus, 20 ng of p24 HIV-1 cell-free
virions was added to apical surfaces in 500 μl of media (10 ng p24/
ml). To propagate cell-associated HIV-1, activated PBMCs were
infected with 20 ng of p24 virus per 106/PBMCs. The dual tropic
HIV-1SF33 strain was highly infectious and therefore infected PBMCs
were maintained for 3–5 days. The R5-tropic HIV-1SF170 and X4-tropic
HIV-192UG029 primary clinical isolates were less infectious, and PBMCs
infected with these viruses were cultured for 7–10 days. Infection was
conﬁrmed by detection using an ELISA for p24 of virus released from
PBMCs, and cells were used for transcytosis if the p24 amount was
approximately 20 ng/ml from 106 cells. Thus, the amounts of cell-free
(20 ng/insert) and cell-associated virus (10–20 ng/ml/106 cells) in
transcytosis experiments were similar. HIV-1-infected PBMCs (106
PBMCs/per ﬁlter insert with approximately 2×105 epithelial cells)
were added to the apical membranes of polarized cells. To the lower
chamber, we added 1 ml of medium containing 106 activated, HIV-
uninfected target PBMCs. Cells were incubated at 37 °C in CO2, and
after transcytosis, the ﬁlter inserts were removed and one-third of the
culture medium with PBMCs from the lower chamber was collected
for detection of HIV-1 p24 using an ELISA, according to the
manufacturer's instructions (Coulter). The remaining PBMCs in thelower chamber were cultured for 7, 10, or 14 days to evaluate
replication of transcytosed virions using a reverse transcriptase assay
(RT), as described previously (Hoffman et al., 1985).
Analysis of innate protein expression and secretion from oral epithelial
cells and their functional activity
For quantitative analysis of innate protein expression, polarized
epithelial cells were immunostained for HBD2, HBD3, and SLPI. Cells
were analyzed by confocal microscopy, and positive cells were counted.
To measure the secretion of HBD2, HBD3, and SLPI from polarized
and non-polarized cells, equal numbers of cells were seeded in ﬁlter
inserts with 12-mm diameters (2×105 cells/insert) or in 24-well
plates (2×105 cells/well). Cells were grown for 10 days, and the
polarity of cells on ﬁlter inserts was conﬁrmed by measuring their
TER. Cells were then washed, and fresh media were added. After
overnight incubation (16 h), media from the apical and basolateral
compartments of polarized cells were collected separately. At the
same time, media from non-polarized cells were also collected.
Culture media from both polarized and non-polarized cells were
ﬁltered through 0.22-μm ﬁlters and analyzed using HBD2, HBD3, and
SLPI ELISA kits (Phoenix Pharmaceutical Inc. and R&D, respectively).
For Western blot detection of human HBD3 and SLPI adult tonsil
epithelial cells, cells were grown under polarized conditions in 6-well
Transwell ﬁlter inserts. Polarized cells were extracted, proteins were
separated on 16% SDS-polyacrylamide gel and blotted with mouse
anti-HBD3 (2 μg/ml) (Abcam) and mouse SLPI (2 μg/ml) (R&D)
antibodies. The protein bands were visualized using ECL detection
reagents (Amersham), and equal protein load was conﬁrmed by
detection of β-actin (Ambio).
To determine the functional role of innate proteins in HIV
inactivation, expression of HBD1, HBD2, HBD3, and SLPI in polarized
adult oral epithelial cells were inhibited using an siRNA approach.
Polarized tongue cells were treated with lipid-based transfection
reagents containing speciﬁc siRNAs (Santa Cruz Biotechnology Inc.)
against the mRNAs of each protein, as described by the manufacturer.
As controls, unrelated (scrambled) siRNAs were used (Santa Cruz
Biotechnology Inc.). The efﬁciency of siRNA transfection was
conﬁrmed using FITC-labeled control siRNA: after 24 h, about 70–
80% cells were positive for siRNA-FITC. After 3 days of siRNA
transfection, polarized cells were used for HIV transcytosis assays
using cell-associated HIV-1SF33. The RT activity of input virus was
evaluated by measuring the RT activity of HIV-infected PBMCs before
transcytosis. After 10 days, the target PBMCs from the lower chambers
were used for evaluation of RT activity.
For intracellular neutralization of HBD2, HBD3, and SLPI in
polarized adult oral epithelial cells, speciﬁc antibodies to these
proteins and nonspeciﬁc isotype antibodies were allowed to be
internalized by polarized adult tongue epithelial cells using the
antibody delivery reagent Ab-DeliverINTM as described by the
manufacturer (OZ Biosciences). The quantity of antibody added to
each insert – which contained about 2×105 cells each – were as
follows: 2 μg/insert of goat anti-HBD2 IgG, 6 μg/insert of monoclonal
mouse anti-HBD3 IgG, and 3 μg/insert mouse monoclonal anti-SLPI
IgG1. The following isotype antibodies were used as controls: 2 μg/
insert of goat IgG and 6 μg/insert of mouse IgG. After 16 h, these cells
were used for cell-associated transcytosis of HIV-1SF33 virus. The RT
activity of input virus was evaluated by measuring activity in HIV-
infected PBMCs before transcytosis. After 7 and 14 days, the target
PBMCs from the lower chambers were examined for RT activity.
Statistical analysis
Differences in RT values of PBMCs infected with trancytosed HIV
were determined by calculation of median values using the Student's
t-test.
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